Held Monday 19 October 2026 · Gold Coast & Shanghai
Australia–China BioInnovation Roundtable 2026
Going Global, Together
In partnership with
Principal partner, partner, and official recognition
Principal Partner
Partner
Official Satellite Event
The Australia–China BioInnovation Roundtable was an official satellite event of AusBiotech's Australia's Biggest Week in Biotech.
Learn more about Australia's Biggest Week in Biotech →About the Roundtable
A bilateral bridge between Australia and China's biotech ecosystems
In its third year, the Roundtable brought senior biotech and pharma leaders, investors, and policymakers from Australia and China into the same room — not a trade-show crowd, but a working session that was built for real partnerships to start.
100+
Senior representatives in person across the Gold Coast and Shanghai in 2026
~60,000
Livestream views in China in 2026
2026 attendees included:
Programme
12:30 – 6:30 PM, Monday 19 October 2026 (Gold Coast)
12:30 PM
Registration and light lunch
Registration ahead of the opening session, with a light lunch.
1:00 PM
Welcome and opening remarks
Alan Cui, Managing Partner, Boson Ventures · Dr Zhou Zhou, Head of Asia-Pacific Sales & Marketing in Testing, WuXi AppTec · with invited guests
1:15 PM
Scene-setter: the Australian ecosystem
Where Australian biotech stands in 2026, and the challenges it faces. Stu Dignam, CEO, AUScelerate.
1:35 PM
The China perspective
The Chinese ecosystem and a first-hand account of how it has developed.
1:55 PM
Panel: Collaboration Beyond Borders
How each ecosystem's push to go global is reshaping the way it operates, and where the two paths cross. Moderated discussion, then open floor.
2:55 PM
Afternoon tea
Refreshments and informal networking.
3:20 PM
Spotlight and technical clinic
A keynote from Dr Yi Jin, Vice President and Chief Toxicologist at WuXi AppTec, then cross-border development in practice — including how the R&D tax incentive works when you engage an offshore partner, answered by an Australian tax specialist and a company that has done it.
4:00 PM
Investor panel
The capital view from both markets.
4:50 PM
Roundtable: capital, partnering and going global
Facilitated, no stage. What makes a cross-border partnership work, and what makes one fail.
5:20 PM
Closing remarks
Reflected on the day and set out what's next for the corridor.
5:30 PM
Networking drinks & reception
Ran through to 6:30 PM.
Speakers
Speakers
Alan Cui
Managing Partner, Boson Ventures
Peter Devine
Company Director, Kinoxis Therapeutics · Former CEO, Uniseed
Stuart Dignam
CEO · AUScelerate
Dr Olivia Geng
Partner · Altea Investments
Jiang Houjia
Founding and Managing Partner · Hongsheng Capital
Riddick Jie
Director · Aeterna Health
Dr Yi Jin
Vice President, Chief Scientific Toxicologist · WuXi AppTec
Frank Li
Executive Director, In Vivo Pharmacology · WuXi AppTec
Christina Lian
Director of Business Development · WuXi AppTec
Dr Jiang Ni
Head of Artificial Intelligence and Assistant to the General Manager · Suzhou Jiashu Medical Technology
Dr Tim Oldham
CEO & Managing Director · AdAlta
Ben Phillis
Head of Investment Fund · UniQuest
Rosie Silk
Senior Manager, R&D Tax & Government Incentives · RSM Australia
Ru Tao
Managing Director – Biotech · Shanghai Guotou Xiandao Fund
Hermann Vorster MP
Assistant Minister for Multicultural Affairs and International Student Attraction · Queensland Government
Mike Wheatcroft
VP of Discovery Sciences · Telix
Dr Zhou Zhou
Head of Asia-Pacific Sales & Marketing in Testing · WuXi AppTec
Who attended
Brought together the people making Australia–China biotech deals happen
Biotech & pharma leaders
Founders, CEOs, CSOs and heads of development from pre-clinical through Phase II, plus R&D and partnering teams from Australian pharma.
Investors & fund managers
Life sciences investors, family offices, and cross-border funds active in Australia–China.
Research & ecosystem leaders
Translational research leaders, institute directors, and commercialisation offices, alongside R&D tax and IP advisers, CROs and clinical trial networks.
Delegates from China
Chinese biotech and pharmaceutical delegates who attended Australia's Biggest Week in Biotech.
Read the full recap of the 2026 Roundtable.
AusBiotech's Australia's Biggest Week in Biotech brought together the biotechnology and life sciences community for a week of sector events, collaboration and connection on the Gold Coast from 19–23 October 2026. The 2026 Australia–China BioInnovation Roundtable was proud to be an official satellite event partner.
Australia's Biggest Week in Biotech →China market entry
Expanding into China?
Market-entry diligence, customer introductions and on-the-ground support across Shanghai and the Greater Bay Area — open to any Australian tech company, not just our portfolio.